Jose Pablo
Miramontes Gonzalez
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (8)
2023
-
Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action
Current Medical Research and Opinion, Vol. 39, Núm. 6, pp. 827-832
2022
-
Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)
BMC Geriatrics, Vol. 22, Núm. 1
-
Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice
Frontiers in Endocrinology, Vol. 13
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
Frontiers in Endocrinology, Vol. 13
-
Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure
Journal of the American Geriatrics Society
2019
-
Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors
Revista Clinica Espanola, Vol. 219, Núm. 4, pp. 208-217
2018
-
The mechanism of action of sodium–glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors
European Journal of Heart Failure